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Abstract
Major Depressive Disorder (MDD) is one of the most prevalent
mental disorders in society. Treatment methods for this disorder
have been the topic of debate among researchers to determine the
most effective method to prevent relapse for individuals with MDD.
Psychotherapy and pharmacotherapy are the most commonly
used treatment methods. Each method, when used on its own, has
advantages and disadvantages in treating the specific symptoms
of MDD. A psychotherapeutic treatment course of Cognitive
Behavioral Therapy (CBT) will focus on treating the behavioral
factors that contribute to MDD (e.g., lack of exercise, inappropriate
coping mechanisms, and inadequate social ties), but a focus on
these factors may leave the biological factors of MDD (e.g., defects
in neurotransmitters, genetics, and brain structure) untreated,
which is the focus of treatment in a pharmacotherapeutic method
using SSRI medications. With a combined treatment course of both
psychotherapy and pharmacotherapy, the behavioral and biological
symptoms associated with MDD may be treated in a focused,
effective manner.
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Major Depressive Disorder (MDD) is one of the most prevalent
and burdensome mental disorders in today’s society (Blais et
al., 2013). Approximately 1 in 5 adults will experience a major
depressive episode at some point in their lifetime (Fakhoury,
2015). Along with a high prevalence rate, MDD has also proven
to be highly recurrent in nature. In a study done by Solomon et
al. (2000), researchers studied a group of individuals with MDD
after completing treatment to determine the likelihood of relapse.
The findings of this study, as shown in Figure 1, demonstrated
that after recovering from MDD, the probability of a first relapse
is 25% after one year, 42% after two years, and 60% after five
years. Following a first relapse, the probability of experiencing a
second relapse is 41% after one year after the relapse, 59% after
two years, and 74% after five years. The findings of this study
show that there is a high probability for relapse for those who
successfully completed treatment, either by way of psychotherapy
or pharmacotherapy. This high probability has led to much
research aimed toward determining whether psychotherapy or
pharmacotherapy is more effective in ensuring a lasting recovery
for those suffering from MDD.
Psychotherapy is a treatment method in which an individual
and a therapist meet in a counseling setting to resolve the issues
that are causing a particular mental illness. Cognitive Behavioral
Therapy (CBT) is one of the most common and effective forms of
psychotherapy used in the treatment of MDD (Wiles et al., 2016).
According to Wiles et al. (2016), “CBT teaches patients skills to help
them better manage their mood, and so has the potential to result
in benefit that is sustained beyond the end of therapy” (p. 137).
Because of the relapsing nature of depression, the skills learned
through CBT can help individuals recognize and manage recurrent
symptoms to prevent further relapse (Petersen, Sprich, & Wilhelm,
2016). Although psychotherapy is effective in treating MDD, it
is mostly aimed at treating the behavioral factors of MDD, such
as coping with stressful life events, lack of exercise, poor coping
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strategies, and sociocultural factors (Neitzke, 2016; Woodend,
Schölmerich, & Denktaş, 2015). With this aim, it does not focus on
treating the biological factors associated with MDD as effectively as
a pharmacotherapeutic method would.
Pharmacotherapy can be defined as the treatment of a mental
disorder using medications and other substances to manage
the symptoms of a particular disorder. Many biological factors
can contribute to MDD. This review will focus on three factors:
neurotransmitters, genetics, and brain structure (Fakhoury, 2015;
Nutt, 2008). According to Nutt (2008), many different types of
antidepressants have been used since their discovery in the 1950s,
but the most effective antidepressant medication appears to be
selective serotonin reuptake inhibitors (SSRIs), which are currently
the most commonly used medications for treating MDD. There are
advantages and disadvantages of treating with pharmacotherapy
alone. Pharmacotherapy may yield faster relief from the symptoms
associated with MDD and is more convenient than taking the time
to meet personally with a psychotherapist; however, because of this,
pharmacotherapy may not treat the underlying causes (T. Salisbury,
personal communication, March 6, 2017). With a focus on treating
the biological factors of MDD, pharmacotherapy can be effective in
short-term treatment; but, without treating the underlying causes of
MDD, a treatment course of pharmacotherapy alone may lead to a
higher probability of relapse.
The fact that neither psychotherapy nor pharmacotherapy can
fully treat all the symptoms of MDD has been the main cause for
debate and research among psychologists to determine which
method is a more effective treatment. Much of the research has
suggested that when choosing one treatment method over the
other, psychotherapy is more effective in preventing relapse of
symptoms (Blackburn, Eunson, & Bishop, 1986; Blais et al., 2013;
Huhn et al., 2014). Although psychotherapy is an effective method
on its own for treating MDD, a combined approach incorporating
both psychotherapy and pharmacotherapy may offer a better
treatment course because a combination of these methods treats
both the biological and behavioral factors associated with MDD.
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An in-depth examination of both methods, first of psychotherapy
and the behavioral factors, followed by pharmacotherapy and the
biological factors, with their advantages and disadvantages, will
show the need for a combined treatment method for MDD.
Psychotherapy
In order to understand the advantages and disadvantages of
psychotherapy as a treatment course for MDD, the behavioral
factors of MDD must first be addressed. Furthermore, an
understanding of these factors might suggest that CBT may be
the best method to address these behavioral factors. This section
discusses both the behavioral factors of MDD and the CBT
treatment method used to treat those factors.
Behavioral Factors of MDD
Behavioral factors have been shown to contribute to the onset and
development of MDD. Woodend et al. (2015) have identified three
specific behavioral factors: lack of exercise, inappropriate coping
mechanisms, and inadequate social ties. This section will examine
these three behavioral factors and discuss the psychotherapeutic
methods through which these factors are treated.
Lack of exercise. According to Woodend et al. (2015), a lack
of physical exercise greatly increases the probability of being
diagnosed with MDD (p. 2319). In a study done by Strawbridge,
Deleger, Roberts, and Kaplan (2002), 1,947 subjects were examined
to determine the effects of physical exercise on reducing the
occurrence of MDD. To define the parameters of physical exercise,
the researchers administered a survey to measure how often
each subject went on long walks, engaged in strenuous exercise,
participated in sports, and went swimming. Subjects answered on
a scale of 1 to 8, with one signifying that they never engaged in
the activity and eight signifying that they participated very often
in the activity. Researchers divided the results into three separate
levels of activity: low (scores from 0-2), medium (scores from 3-5),
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and high (scores from 6-8). Depression was measured by the criteria
found in the DSM-IV. The prevalence of depression was 11% for
subjects who reported low physical activity, 6.1% for subjects who
reported medium physical activity, and only 3% for subjects who
reported high physical activity (Strawbridge et al., 2002). These
results suggest that those who do not engage regularly in physical
activity are nearly four times more likely to experience depression
than those who exercise on a regular basis.
Maladaptive coping mechanisms. A coping mechanism is the
source individuals turn to in a stressful or otherwise negative life
situation (Woodend et al., 2015). Two different ways to cope exist
when facing a stressful life situation: adaptive and maladaptive
coping (Mahmoud, Staten, Hall, & Lennie, 2012). According to
Mahmoud et al. (2012), an adaptive coping strategy involves
identifying a stressful situation, seeking out and finding help,
and acting in a way to resolve the situation. By following the
appropriate steps, an adaptive strategy will not only result in a
resolution of the situation but will also result in psychological and
emotional adjustment. A maladaptive coping strategy involves the
individual withdrawing themselves from those around them and
avoiding the stressful situation altogether; paradoxically, avoiding
the stressful situation usually contributes to added measures of
stress, which can lead to both anxiety and depression, potentially
increasing the likelihood of a major depressive episode (Mahmoud
et al., 2012). Based on this understanding, as individuals incorporate
more adaptive coping skills, there may be a decreased amount of
stress that could potentially trigger a major depressive episode.
Mahmoud et al. (2012) conducted a study on college students to
measure the correlation between coping strategies and depression
and anxiety levels. In this study, 1,700 students were selected at
random and administered the Depression-Anxiety Stress Scale-21
(DASS-21) and the Brief COPE Inventory (BCI) to assess this
relationship. The survey found that a positive correlation between
maladaptive coping strategies and depression existed in these
students. Those who reported maladaptive strategies also scored
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significantly higher in their levels of depression (Mahmoud et al.,
2012). These results suggest that inappropriate coping mechanisms
may play a significant role in the development of depression.
Inadequate social ties. Relationships with family, friends, and
other members of the community can play a role in the onset and
development of MDD (Woodend et al., 2015). According to Lin,
Ye, and Ensel (1999), social ties can affect the mental health of an
individual in many different ways. Lin et al. (1999) divided the
necessary social needs into three different categories: perceived
and actual support, emotional and instrumental support, and
routine and crisis support (p. 346). Without any one of these
support categories, the risk of MDD increases. Perceived and
actual support is the support that a person both perceives to
receive and actually receives. It is possible to have one without
the other, but to have the full effect of the support, both elements
need to be present. Emotional support is having a social source
to express feelings, vent frustrations, seek understanding, and
build self-esteem while instrumental support is a social source
through which tangible assistance can be achieved (e.g., help with
chores, money, and school). Routine support is having a source
of support for regular, day-to-day activities such as child care,
grocery shopping, and transportation; in contrast, crisis support
is having a source of support in high stress situations such as
divorce, car accidents, and medical emergencies (Lin et al., 1999).
It is important to have support of each of these kinds to be able
to manage stressful situations that could trigger a depressive
episode. With each category covered, the likelihood of depression
decreases significantly.
A study conducted by Lin et al. (1999) in which 1,261 subjects
were surveyed regarding their support structures and depression
levels illustrates how inadequate social ties increases the likelihood
of MDD. Out of all the categories that subjects were surveyed on,
the categories that decreased depression levels most effectively were
number of weekly contacts, the presence of an intimate relationship,
and the presence of a strong social network (p. 352). With these
types of social support, depression decreases, and as individuals
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begin to isolate themselves from others, the probability of having
a major depressive episode increases significantly (Woodend et al.,
2015). The results of this study show that as individuals develop
these types of social ties, the likelihood of a major depressive
episode decreases significantly.
While many other behavioral factors play a role in the
development of MDD, lack of exercise, maladaptive coping skills,
and inadequate social ties provide a foundation for understanding
why a psychotherapeutic method of treatment is effective in the
treatment course of MDD. CBT may be an effective method for
addressing these behavioral factors of MDD.
Cognitive Behavioral Therapy
The goal of CBT is to help individuals develop skills to
recognize and prevent symptoms outside of therapy. According to
Wiles et al. (2016), “CBT teaches patients skills to help them better
manage their mood, and so has the potential to result in benefit that
is sustained beyond the end of therapy” (p. 137). This section will
overview the methods used in a therapeutic setting in treating and
preventing symptoms associated with MDD.
The main focus of CBT is known as case conceptualization. Case
conceptualization is a therapist’s method of helping the individual
analyze potential triggers, recognize symptoms, and successfully
overcome symptoms (Petersen et al., 2016). According to Petersen
et al. (2016), in case conceptualization the therapist follows the
Antecedent, Behavior, Consequence (ABC) Model (p. 8). This
model allows the client to analyze what happened before, during,
and after the onset of symptoms, enabling them to manage the
behavioral factors manifest.
The first focus of the ABC Model is the antecedent, which
focuses on analyzing the events that occur just before the onset
of a symptom. The second focus, behavior, helps the individual
determine the behaviors engaged as a result in the onset of
symptoms. The final focus, consequence, helps the individual
determine the positive or negative results of the behavior which
helps to determine the likelihood that a behavior will be repeated
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(Peterson et al., 2016). With the help of a therapist, the three
focuses of the ABC model can help individuals successfully think
through the onset of symptomology to reduce the severity of those
symptoms over time.
This method of treatment has been shown to be effective in
addressing treatment-resistant depression. In a study done by
Wiles et al. (2016), 469 subjects were studied to determine the
effectiveness of CBT. Half were chosen at random to participate in
a CBT program while the other half continued to be treated with
medications and other therapeutic methods. A treatment course
was followed with an average length of 12 therapy sessions.
After 46 months, the researches followed up with each patient.
On average, those in the group receiving CBT treatment scored
significantly lower on the depression scale than those who
received the usual treatment course (Wiles et al., 2016, pp. 140141). This study suggests that the skills learned in CBT as a result
of the ABC Model can help reduce the probability of relapse of
MDD symptoms.
While it may seem that a psychotherapeutic method with a
focus on CBT can effectively treat MDD on its own, this approach
also has disadvantages. According to Dr. T. Salisbury (personal
communication, March 6, 2017), a practicing clinical psychologist,
it is difficult for many individuals experiencing MDD to find the
motivation to take the time to meet with a therapist as often as
it takes to treat MDD. Additionally, Wiles et al. (2016) explains
how psychotherapy is a long-term treatment and progress
within psychotherapy can be slow and cause individuals to be
discouraged and not follow through with the treatment course.
However, the main disadvantage to a psychotherapeutic approach
is that the biological factors of MDD are not focused on and may
be left untreated.
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Pharmacotherapy
Knowing that a treatment course of psychotherapy alone
does not focus on the biological factors of MDD, a need arises for
pharmacotherapy. This section will address that need and will
suggest a pharmacotherapeutic treatment course using SSRIs to
treat the biological factors associated with MDD.
Biological Factors of MDD
While it is true that the behavioral factors studied in the
previous section play a significant role in the development of MDD,
if the biological factors are left untreated, the whole scope of this
disorder may not be fully treated. Fakhoury (2015) suggests three
biological factors that influence the development and recurrence of
MDD: neurotransmitters, genetics, and brain structure.
Neurotransmitters. Neurotransmitters deliver messages
between neurons in the brain and play a significant role in
depression levels (Nutt, 2008). The three main neurotransmitters
that play a role in depression are dopamine, norepinephrine, and
serotonin (reference). Each of these neurotransmitters contributes
to different depressive symptoms. Dopamine regulates motivation,
attention, and overall pleasure; norepinephrine regulates alertness,
energy, and overall interest in life; and serotonin regulates
anxiety, obsessions, and compulsions (Nutt, 2008, p. 6). In treating
abnormalities in these neurotransmitters, a practitioner may attempt
to raise the levels of all three simultaneously, which would increase
mood overall; however, focusing on the specific symptoms being
presented by each neurotransmitter could be more effective in the
overall treatment course.
Defects in various neurotransmitters can lead to differing
symptoms and types of depression. Nutt (2008) describes two types
of depression as “an increase of negative affect and a loss of positive
affect” (p. 6). An increase of negative affect refers to seeing the
world as hostile and negative, and this type of depression generally
leads to the development of anxiety disorders; a loss of positive
affect refers to a person losing interest in normal activities and
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leads to a loss of motivation (Nutt, 2008). If a practitioner focuses on
whether an individual is experiencing an increase of negative affect
or a decrease in positive affect, then a specific pharmacotherapeutic
treatment course can be formed and the pertinent neurotransmitter
levels can be corrected to decrease the symptoms of depression.
Research suggests that pharmacotherapeutic methods are not
always needed to raise neurotransmitter levels. For example, a
study done by Sutoo and Akiyama (1996) showed that exercising
between 15 and 60 minutes each day can significantly raise
dopamine levels. However, a focus on only the behavioral factors
of MDD may not give enough attention to the correction of
neurotransmitter levels in the brain needed to provide the most
effective treatment course.
Genetics. There seems to be a link between family history of
MDD and the likelihood of an individual developing this disorder
(Fakhoury, 2015). According to Fakhoury (2015), several genes
contribute to the development of MDD in an individual (see Table
1). As seen in Table 1, genes contribute to the processes involved in
MDD. For example, the serotonin transporter protein is responsible
for transporting serotonin from the synapses of one neuron to the
presynaptic space of another; the tryptophan hydroxylase 2 gene is
involved in the synthesis of serotonin; and the insulin-like growth
factor 1 gene regulates many processes involved in the development
of MDD. These genetic factors play a role in depression, and if
people are born with variant in these genes, they already have a
natural susceptibility to developing MDD in their lifetime. Because
of this, when these people experience normal stressors, they
are more likely to exhibit symptoms of depression, which may
eventually lead to a diagnosis of MDD.
Brain structure. Through the advancement of imaging
technology, discoveries in brain function have shown that
depression levels can be linked to the hippocampus, amygdala,
and prefrontal cortex region of the brain (Fakhoury, 2015). Each
of these parts of the brain plays a separate role in mood and the
expression of emotion, and defects in these parts of the brain
contribute separate symptoms of depression. The hippocampus
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is the portion of the brain that processes information and stores
and analyzes memories (Marchand, Dilda, Jensen, & Wahlen,
2005). Fakhoury (2015) asserts that a defect in this portion of the
brain contributes to impaired memory function and an overall
depressed mood state. In contrast, Marchand et al. (2005) suggests
the amygdala is responsible for emotional learning and emotional
response to stimuli. In those with MDD, the amygdala has been
found to be undersized, causing slower responses to emotional
situations. Furthermore, the prefrontal cortex is believed to be the
most involved part of the brain in MDD as it is involved with mood
regulation, executive reasoning, the expression of personality, and
social behaviors (Marchand et al., 2015). In the case of defect in each
of these parts of the brain, the functioning of neurotransmitters
is impaired (Fakhoury, 2015). This makes individuals with
abnormalities of the hippocampus, amygdala, and prefrontal cortex
more likely to develop MDD in their lifetime.
Selective Serotonin Reuptake Inhibitors (SSRIs)
Research seems to suggest that defects in levels of
neurotransmitters, genetic predispositions, and differences in
brain structures can impair the ability of the brain to normally
send signals between neurons by way of neurotransmitters. Many
antidepressant medications have been developed and tested
over the past decades, but the most effective and commonly
used medications appear to be SSRIs (Nutt, 2008, p. 4-5). The
goal of SSRIs is to raise activity levels of neurotransmitters in
the brain, and a practitioner will normally prescribe daily doses
which will indirectly raise serotonin levels by blocking reuptake
(Vaswani, Linda, & Ramesh, 2003). With the SSRI drug regulating
the production of serotonin and other neurotransmitters, brain
functioning improves, allowing the individual to find relief from
the symptoms they are experiencing.
The development of SSRIs to treat those struggling with MDD
has significantly improved the short-term treatment of this disorder.
It has allowed individuals to experience faster progress than
progress experienced through a psychotherapeutic treatment course
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(T. Salisbury, personal communication, March 6, 2017). However,
just as psychotherapy may not treat the biological factors of MDD,
a treatment course of pharmacotherapy alone may not completely
treat the potential behavioral factors, and when those factors are
left untreated, the possibility of relapse may increase significantly
(Guidi, Tomba, & Fava, 2015). In a comprehensive meta-analysis
done by Guidi et al. (2015), a long-term treatment course of
pharmacotherapy alone tended to lead to higher relapse rates,
because the medications brought negative side effects; there were
potential negative reactions with medical conditions to the drugs;
and individuals tended to have negative withdrawal symptoms
upon discontinuing drug therapy. With these factors in mind, a
pharmacotherapeutic method of treatment alone may not offer the
best treatment course for those struggling with MDD.
Combined Treatment
Much research has been done on the efficacy of
pharmacotherapy and psychotherapy in treating MDD. When
studying both methods on their own, much of the research suggests
that psychotherapy could offer a better treatment course than
pharmacotherapy (Blais et al., 2013; Huhn et al., 2014). However,
studies by both Blackburn et al. (1986) and Wiles et al. (2016)
showed that a combination of psychotherapy and pharmacotherapy
can be most effective. Wiles et al. (2016) studied 469 individuals
receiving treatment for MDD. Subjects were divided randomly
into a combined treatment group and a group receiving treatment
with antidepressants only and were re-assessed 46 months after
ending treatment. Those who took part in the combined treatment
group scored significantly lower in depression levels than the
control group. In the study performed by Blackburn et al. (1986),
subjects were randomly divided into three treatment groups:
psychotherapy, pharmacotherapy, and a combined treatment
group. Two years after treatment, researchers followed up to
determine relapse rates among the groups. The findings of this
follow-up showed that 30% of those who received pharmacotherapy
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experienced at least one relapse of depressive symptoms, 6% of
those who participated in psychotherapy experienced relapse,
while no subjects who received a combined treatment method
experienced a relapse. While more research needs to be done to
determine the clinical significance of these studies, more effective
treatment seems to come from a combination of psychotherapeutic
and pharmacotherapeutic treatment methods.
Conclusion
Many factors need to be considered when suggesting a
treatment course for MDD. As shown in this review, both
psychotherapy and pharmacotherapy have many advantages for
patients in treatment for this disorder. Those suffering from MDD
often exhibit many behavioral factors that may be best addressed
in a therapeutic setting. With the help of a therapist through CBT,
individuals can receive help in time management to make adequate
time for exercise which will help increase dopamine levels in the
brain (Woodend et al., 2015). Further, a therapist can assist in
developing positive coping mechanisms to respond to stressful
situations in healthy ways which can also assist in developing
healthy social ties to help through the healing process (Mahmoud et
al., 2012; Petersen et al., 2016; Woodend et al., 2015). The goal of the
therapeutic process is to prevent relapse by teaching skills to put
into practice as symptoms begin to emerge (Wiles et al., 2016).
Individuals with MDD also exhibit many biological factors,
such as deficits in neurotransmitters, abnormal brain structure,
and genetics. While these factors could be improved through
psychotherapy, a treatment plan focused on pharmacotherapy
could provide more effective treatment. SSRIs can be used to
treat deficiencies in neurotransmitter levels, genetics, and brain
structures (Fakhoury, 2015; Nutt, 2008). While pharmacotherapy
may be effective in treating the symptoms in the short term, the
goal of this method does not include a long-term treatment plan to
prevent relapse, which is why psychotherapy on its own may be the
preferred treatment course.
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Although psychotherapy has shown benefits over
pharmacotherapy, a patient suffering from MDD should not
be forced to choose one method over the other. A combined
treatment of both methods may offer a better course. By
receiving a combination of psychotherapy and pharmacotherapy,
the patient will benefit from the long-term advantages of
psychotherapy and CBT while also benefiting from the shortterm effects of pharmacotherapy and SSRIs. In following this
treatment course, both treatment methods complement each
other, as psychotherapy treats the behavioral factors that
pharmacotherapy does not focus on treating, and inversely,
pharmacotherapy focuses on treating the biological factors that
psychotherapy does not focus on treating.
While existing research has shown that a combined treatment
method has an advantage over treating with either psychotherapy
or pharmacotherapy alone, more research is needed to determine
the clinical significance of existing findings. Therapists and
other mental health professions need to implement a combined
approach to treat both the behavioral and biological factors of
MDD. As more individuals receive a combined treatment course,
symptoms of MDD can stay in remission and the probability of
relapse can decrease.
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Appendix

Figure 1. Bar graphs represent the probability of relapse post-treatment.
Adapted from “Multiple Recurrences of Major Depressive Disorder,” by
D. A. Solomon, M. B. Keller, A. C. Leon, T. I. Mueller, P. W. Lavori, M. T.
Shea, ... and J. Endicott, 2000, American Journal of Psychiatry, 157(2), pp. 229233.
Table 1
Genes Involved in Development of MDD

Note. This table outlines a number of genes that are involved in the
development of Major Depressive Disorder. Adapted from “New Insights
into the Neurobiological Mechanisms of Major Depressive Disorders,” by
M. Fakhoury, 2015, General Hospital Psychiatry, 37(2), pp. 172-177.

214
https://scholarsarchive.byu.edu/intuition/vol13/iss3/11
Intuition guts.indd 214

16
11/13/19 10:22 PM

Van Dyke: Psychotherapy vs. Pharmacotherapy

215
Published by BYU ScholarsArchive, 2018
Intuition guts.indd 215

17
11/13/19 10:22 PM

Intuition: The BYU Undergraduate Journal of Psychology, Vol. 13 [2018], Iss. 3, Art. 11

216
https://scholarsarchive.byu.edu/intuition/vol13/iss3/11
Intuition guts.indd 216

18
11/13/19 10:22 PM

